The two-pore-domain or tandem pore domain potassium channels are a family of 15 members that form what is known as leak channels which possess Goldman-Hodgkin-Katz (open) rectification.[1] These channels are regulated by several mechanisms including signaling lipids, oxygen tension, pH, mechanical stretch, and G-proteins.[2] Two-pore-domain potassium channels correspond structurally to a inward-rectifier potassium channel α-subunits. Each inward-rectifier potassium channel α-subunit is composed of two transmembrane α-helices, a pore helix and a potassium ion selectivity filter sequence and assembles into a tetramer forming the complete channel.[3] The two-pore domain potassium channels instead are dimers where each subunit is essentially two α-subunits joined together.[4]
Each single channel does not have two pores; the name of the channel comes from the fact that each subunit has two P (pore) domains in its primary sequence.[5] To quote Rang and Dale (2015), "The nomenclature is misleading, especially when they are incorrectly referred to as two-pore channels".[6]
A decrease in these leak channels activity is known as 'channel arrest', which reduces oxygen consumption[7] and allows animals to survive anoxia.[8]
Below is a list of the 15 known two-pore-domain human potassium channels:[1]
See also
References
- ^ a b Goldstein SA, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S (December 2005). "International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels". Pharmacological Reviews. 57 (4): 527–540. doi:10.1124/pr.57.4.12. PMID 16382106. S2CID 7356601.
- ^ a b c d e f g h i j k l m n Enyedi P, Czirják G (April 2010). "Molecular background of leak K+ currents: two-pore domain potassium channels". Physiological Reviews. 90 (2): 559–605. doi:10.1152/physrev.00029.2009. PMID 20393194.
- ^ Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, et al. (April 1998). "The structure of the potassium channel: molecular basis of K+ conduction and selectivity". Science. 280 (5360): 69–77. Bibcode:1998Sci...280...69D. doi:10.1126/science.280.5360.69. PMID 9525859.
- ^ Miller AN, Long SB (January 2012). "Crystal structure of the human two-pore domain potassium channel K2P1". Science. 335 (6067): 432–436. Bibcode:2012Sci...335..432M. doi:10.1126/science.1213274. PMID 22282804. S2CID 206537279.
- ^ Baggetta AM, Bayliss DA, Czirják G, Enyedi P, Goldstein SA, Lesage F, Minor Jr DL, Plant LD, Sepúlveda F. "Two P domain potassium channels". GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology. Retrieved 2019-05-28.
- ^ Rang HP (2003). Pharmacology (8 ed.). Edinburgh: Churchill Livingstone. p. 59. ISBN 978-0-443-07145-4.
- ^ Lutz, Peter L.; Milton, Sarah L. (2004-08-15). "Negotiating brain anoxia survival in the turtle". Journal of Experimental Biology. 207 (18): 3141–3147. Bibcode:2004JExpB.207.3141L. doi:10.1242/jeb.01056. ISSN 1477-9145. PMID 15299035.
- ^ Welker, Alexis F.; Moreira, Daniel C.; Campos, Élida G.; Hermes-Lima, Marcelo (August 2013). "Role of redox metabolism for adaptation of aquatic animals to drastic changes in oxygen availability". Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology. 165 (4): 384–404. doi:10.1016/j.cbpa.2013.04.003. PMID 23587877.
- ^ Gutman GA, Chandy KG, Adelman JP, Aiyar J, Bayliss DA, Clapham DE, et al. (December 2003). "International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels". Pharmacological Reviews. 55 (4): 583–586. doi:10.1124/pr.55.4.9. PMID 14657415. S2CID 34963430.
- ^ a b c d e f g h i j k l m Lotshaw DP (2007). "Biophysical, pharmacological, and functional characteristics of cloned and native mammalian two-pore domain K+ channels". Cell Biochemistry and Biophysics. 47 (2): 209–256. doi:10.1007/s12013-007-0007-8. PMID 17652773. S2CID 12759521.
- ^ Fink M, Lesage F, Duprat F, Heurteaux C, Reyes R, Fosset M, Lazdunski M (June 1998). "A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids". The EMBO Journal. 17 (12): 3297–3308. doi:10.1093/emboj/17.12.3297. PMC 1170668. PMID 9628867.
- ^ Goldstein SA, Bockenhauer D, O'Kelly I, Zilberberg N (March 2001). "Potassium leak channels and the KCNK family of two-P-domain subunits". Nature Reviews. Neuroscience. 2 (3): 175–184. doi:10.1038/35058574. PMID 11256078. S2CID 9682396.
- ^ Sano Y, Inamura K, Miyake A, Mochizuki S, Kitada C, Yokoi H, et al. (July 2003). "A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord". The Journal of Biological Chemistry. 278 (30): 27406–27412. doi:10.1074/jbc.M206810200. PMID 12754259.
- ^ Czirják G, Tóth ZE, Enyedi P (April 2004). "The two-pore domain K+ channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin". The Journal of Biological Chemistry. 279 (18): 18550–18558. doi:10.1074/jbc.M312229200. PMID 14981085.
External links
Ion channel modulators |
---|
Calcium | VDCCsTooltip Voltage-dependent calcium channels | |
---|
|
---|
Potassium | |
---|
Sodium | VGSCsTooltip Voltage-gated sodium channels | Blockers |
- Antiarrhythmics (class I): Ajmaline
- Aprindine
- Disopyramide
- Dronedarone
- Encainide
- Flecainide
- Lidocaine
- Lorajmine
- Lorcainide
- Mexiletine
- Moricizine
- Pilsicainide
- Prajmaline
- Procainamide
- Propafenone
- Quinidine
- Sparteine
- Tocainide
- Anticonvulsants: Acetylpheneturide
- Carbamazepine
- Cenobamate
- Chlorphenacemide
- Elpetrigine
- Eslicarbazepine acetate
- Ethotoin
- Fosphenytoin
- Lamotrigine
- Lacosamide
- Licarbazepine
- Mephenytoin
- Oxcarbazepine
- Oxitriptyline
- Phenacemide
- Pheneturide
- Phenytoin
- Rufinamide
- Sipatrigine
- Topiramate
- Sodium valproate
- Valnoctamide
- Valproate pivoxil
- Valproate semisodium
- Valproic acid
- Valpromide
- Zonisamide
- Local anesthetics: pFBT
- Amylocaine
- Articaine
- Benzocaine
- Bupivacaine (Levobupivacaine, Ropivacaine)
- Butacaine
- Butamben
- Chloroprocaine
- Cinchocaine
- Cocaine
- Cyclomethycaine
- Dimethocaine
- Diphenhydramine
- Etidocaine
- Hexylcaine
- Iontocaine
- Lidocaine
- Mepivacaine
- Meprylcaine
- Metabutoxycaine
- Orthocaine
- Piperocaine
- Prilocaine
- Procaine
- Propoxycaine
- Proxymetacaine
- Risocaine
- Tetracaine
- Trimecaine
- Analgesics: AZD-3161
- DSP-2230
- Funapide
- GDC-0276
- NKTR-171
- PF-04531083
- PF-05089771
- Ralfinamide
- Raxatrigine
- RG7893 (GDC-0287)
- Suzetrigine
- Others: Buprenorphine
- Evenamide
- Menthol (mint)
- Safinamide
- Tricyclic antidepressants
|
---|
Activators | |
---|
|
---|
ENaCTooltip Epithelial sodium channel | Blockers |
- Amiloride
- Benzamil
- Triamterene
|
---|
Activators | |
---|
|
---|
ASICsTooltip Acid-sensing ion channel | Blockers |
- A-317567
- Amiloride
- Aspirin
- Ibuprofen
- PcTX1
|
---|
|
---|
|
---|
Chloride | CaCCsTooltip Calcium-activated chloride channel | Blockers |
- Crofelemer
- DIDS
- Ethacrynic acid
- Flufenamic acid
- Fluoxetine
- Furosemide
- Glibenclamide
- Mefloquine
- Mibefradil
- Niflumic acid
|
---|
Activators | |
---|
|
---|
CFTRTooltip Cystic fibrosis transmembrane conductance regulator | Blockers |
- Glibenclamide
- Lonidamine
- Piretanide
|
---|
Activators |
- 1,7-Phenanthroline
- 1,10-Phenanthroline
- 4,7-Phenanthroline
- 7,8-Benzoquinoline
- Ivacaftor
- Phenanthridine
|
---|
|
---|
Unsorted | Blockers |
- Bumetanide
- Flufenamic acid
- Meclofenamic acid
- Mefenamic acid
- Mepacrine
- Niflumic acid
- Talniflumate
- Tolfenamic acid
- Trifluoperazine
|
---|
|
---|
|
---|
Others | TRPsTooltip Transient receptor potential channels | |
---|
LGICsTooltip Ligand gated ion channels | |
---|
|
---|
See also: Receptor/signaling modulators • Transient receptor potential channel modulators |